Clinical Trial: Oral THC Significantly Reduces Agitation in Alzheimer’s Patients
Compared to the placebo group, subjects who consumed dronabinol experienced a 30 percent reduction in agitation.
The post Clinical Trial: Oral THC Significantly Reduces Agitation in Alzheimer’s Patients appeared first on NORML.
Comments
Post a Comment